biopharma

NORTH CHICAGO, Ill., May 27, 2026 AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZ™...

COPENHAGEN, Denmark, May 26, 2026 Adcendo ApS has announced a new clinical collaboration and supply agreement with MSD (Merck...

SEATTLE, May 20, 2026 Atossa Therapeutics announced that a new scientific manuscript exploring the utrophin-modulation potential of (Z)-endoxifen in...

WILMETTE, Ill., May 19, 2026 Monopar Therapeutics announced the publication of new Phase 2 clinical trial data showing that...

TARRYTOWN, N.Y., May 18, 2026 Regeneron Pharmaceuticals has announced a major strategic collaboration with Parabilis Medicines valued at up...

PARIS, France, May 18, 2026 Sanofi has announced positive Phase 2 ElevAATe trial results demonstrating that investigational therapy efdoralprin...

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; and SHANGHAI, China, May 18, 2026 Harbour BioMed announced promising preclinical data for LET003, its...

HONG KONG, May 15, 2026 Akeso, Inc. announced positive Phase II clinical trial results for ligufalimab (AK117) in frontline...

PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...

MUMBAI, India and TOKYO, Japan, April 16, 2026 Piramal Pharma Solutions (PPS) and Ajinomoto Bio-Pharma Services have announced a...